NasdaqGS:JAZZPharmaceuticals
Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Mixed Recent Returns And A 5.7% Undervaluation Estimate
Recent performance snapshot for Jazz Pharmaceuticals (JAZZ)
Jazz Pharmaceuticals (JAZZ) has attracted attention after a period of mixed short term moves and stronger longer term returns, with the stock closing at $188.69 and showing positive figures across several multi year horizons.
See our latest analysis for Jazz Pharmaceuticals.
Recent moves have been choppy, with a 1 day share price return of 1.08% and a 7 day share price return showing a 4.14% decline. However, the 30 day share price...